Clinical Trial Update: Phase II/III of Live Attenuated Mumps (F-genotype) Vaccine (Human Diploid Cell, KMB-17) in Healthy Children Aged 5-11 [Phase 2, Phase 3]

View source ↗

Summary

Phase II/III trial update for a live attenuated Mumps vaccine (F-genotype) in healthy children aged 5-11; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epidemic Parotitis
• Mumps

Drugs mentioned

• KMB-17 (live attenuated mumps vaccine (F-genotype) in human diploid cell)

Snippet

Sponsor: Institute of Medical Biology, Chinese Academy of Medical Sciences | Conditions: Epidemic Parotitis, Mumps | Phase 2, Phase 3 | Status: UNKNOWN